ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Archives for 2023

Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

Erin Jungmeyer
on: March 21, 2023In: Evolving Standards of Care, Industry News & Regulatory Approvals
Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

In a recent interview with ILCN, the US FDA’s Dr. Harpreet Singh discusses the confirmatory Pragmatica-Lung trial and how the agency’s new pragmatic approach to trial design can streamline research and ultimately benefit patients. Read more


New Texas Lung Cancer Conference Planned with Busy Clinicians in Mind

Erin Jungmeyer
on: March 21, 2023In: Meeting News
New Texas Lung Cancer Conference Planned with Busy Clinicians in Mind

Stephen Liu, MD, and Tina Cascone, MD, PhD, share what attendees can expect at the first ever Texas Lung Cancer Conference, an upcoming two-day CME meeting endorsed by the IASLC. Read more

ILCN Editor Dr. Corey J. Langer Reflects on the ‘Fantastic Voyage’ From Nihilism to Hope in Thoracic Oncology

Nick Ippolito
on: March 21, 2023In: Meeting News
ILCN Editor Dr. Corey J. Langer Reflects on the ‘Fantastic Voyage’ From Nihilism to Hope in Thoracic Oncology

In addressing fellow TTLC 23 faculty, Dr. Langer recounted the perils and pitfalls, promises and poetry he has experienced in his 35 years in the field. Read more

Specialists Debate the Merits of Lorlatinib as a Universal First-Line Treatment for ALK+ Patients

Nick Ippolito
on: March 21, 2023In: Meeting News
Specialists Debate the Merits of Lorlatinib as a Universal First-Line Treatment for ALK+ Patients

Dr. Lyudmila Bazhenova argues the drug’s superior PFS makes it the best first choice; however Dr. Justin Gainor says toxicity data show it may not be right for all patients. Read more

Study Explores First-Line Osimertinib for NSCLC Patients with Uncommon EGFR Mutations

Erin Jungmeyer
on: March 21, 2023In: Meeting News
Study Explores First-Line Osimertinib for NSCLC Patients with Uncommon EGFR Mutations

During TTLC 23, Johns Hopkins’ Tia Cheunkarndee presented data that highlight the vast heterogeneity of mutations—and their variable response to treatment. Read more

Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says

Erin Jungmeyer
on: March 07, 2023In: Evolving Standards of Care, Industry News & Regulatory Approvals, Uncategorized
Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says

In a recent interview with ILCN, Dr. Karen Reckamp discussed the overall survival implications from the phase II Lung-MAP study and how the phase III follow-up Pragmatica-Lung trial aims to confirm that specific endpoint. Read more

Tobacco Control Impacts Everyone in Respiratory Medicine, JTO CRR Editor Says

John Austin
on: March 07, 2023In: Society News, Tobacco Control & Smoking Cessation
Tobacco Control Impacts Everyone in Respiratory Medicine, JTO CRR Editor Says

In a Q&A with ILCN, new JTO Clinical and Research Reports Editor-in-Chief Dr. Emily Stone discusses her passion for tobacco control and the importance of open-access journals in elevating research globally. Read more

Patient Perspective: ‘Scanxiety’ Triggered by Cancer, Not Scans

Dusty Donaldson
on: March 07, 2023In: Patient Advocacy
Patient Perspective: ‘Scanxiety’ Triggered by Cancer, Not Scans

Patient advocate Dusty Donaldson says for most patients regular surveillance is not the problem and points out limitations of data that fail to show better outcomes with frequent scanning. Read more

TTLC Keynote Speaker Explores Progress, Potential Breakthroughs of SCLC Therapies

Nick Ippolito
on: March 07, 2023In: Meeting News
TTLC Keynote Speaker Explores Progress, Potential Breakthroughs of SCLC Therapies

During the Targeted Therapies of Lung Cancer meeting, MD Anderson’s Dr. Lauren Byers celebrated recent advances and highlighted areas in need of further research. Read more

Experts Debate TKI Use After Disease Progression for Patients with EGFR Mutations

Nick Ippolito
on: March 07, 2023In: Meeting News
Experts Debate TKI Use After Disease Progression for Patients with EGFR Mutations

During TTLC 23, Drs. Balazs Halmos and Mark Socinski presented the evidence for and against continued tyrosine kinase inhibitors use with chemotherapy for EGFR-positive patients with disease progression. Read more

123
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy